200 related articles for article (PubMed ID: 37418843)
1. Sarcopenic obesity and its relation with muscle quality and mortality in patients on chronic hemodialysis.
Sabatino A; Avesani CM; Regolisti G; Adinolfi M; Benigno G; Delsante M; Fiaccadori E; Gandolfini I
Clin Nutr; 2023 Aug; 42(8):1359-1368. PubMed ID: 37418843
[TBL] [Abstract][Full Text] [Related]
2. Association between sarcopenic obesity and poor muscle quality based on muscle quality map and abdominal computed tomography.
Cho YK; Jung HN; Kim EH; Lee MJ; Park JY; Lee WJ; Kim HK; Jung CH
Obesity (Silver Spring); 2023 Jun; 31(6):1547-1557. PubMed ID: 37133436
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.
Montano-Loza AJ; Angulo P; Meza-Junco J; Prado CM; Sawyer MB; Beaumont C; Esfandiari N; Ma M; Baracos VE
J Cachexia Sarcopenia Muscle; 2016 May; 7(2):126-35. PubMed ID: 27493866
[TBL] [Abstract][Full Text] [Related]
4. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
5. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
[TBL] [Abstract][Full Text] [Related]
6. Significant Association of Diabetes With Mortality of Chronic Hemodialysis Patients, Independent of the Presence of Obesity, Sarcopenia, and Sarcopenic Obesity.
Ishimura E; Okuno S; Nakatani S; Mori K; Miyawaki J; Okazaki H; Sugie N; Norimine K; Yamakawa K; Tsujimoto Y; Shoji S; Inaba M; Yamakawa T; Emoto M
J Ren Nutr; 2022 Jan; 32(1):94-101. PubMed ID: 34465504
[TBL] [Abstract][Full Text] [Related]
7. Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
Xu MC; Huelster HL; Hatcher JB; Avulova S; Stocks BT; Glaser ZA; Moses KA; Silver HJ
J Urol; 2021 Mar; 205(3):800-805. PubMed ID: 33080148
[TBL] [Abstract][Full Text] [Related]
8. Myosteatosis, the More Significant Predictor of Outcome: An Analysis of the Impact of Myosteatosis, Sarcopenia, and Sarcopenic Obesity on Liver Transplant Outcomes in Johannesburg, South Africa.
Irwin NEA; Fabian J; Hari KR; Lorentz L; Mahomed A; Botha JF
Exp Clin Transplant; 2021 Sep; 19(9):948-955. PubMed ID: 34387151
[TBL] [Abstract][Full Text] [Related]
9. Different computed tomography parameters for defining myosteatosis in patients with advanced non-small cell lung cancer.
Zhang W; Tang J; Tang H; Xie L; Wang J; Wu J; Yang M
Clin Nutr; 2023 Dec; 42(12):2414-2421. PubMed ID: 37871482
[TBL] [Abstract][Full Text] [Related]
10. Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity.
Kim HK; Bae SJ; Lee MJ; Kim EH; Park H; Kim HS; Cho YK; Jung CH; Lee WJ; Choe J
Clin Mol Hepatol; 2023 Oct; 29(4):987-1001. PubMed ID: 37403320
[TBL] [Abstract][Full Text] [Related]
11. The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer.
Şahin MEH; Akbaş F; Yardimci AH; Şahin E
BMC Cancer; 2023 Sep; 23(1):911. PubMed ID: 37770828
[TBL] [Abstract][Full Text] [Related]
12. The Prevalence Rate of Adult Sarcopenic Obesity and Correlation of Appendicular Skeletal Muscle Mass Index with Body Mass Index, Percent Body Fat, Waist-Hip Ratio, Basal Metabolic Rate, and Visceral Fat Area.
Luo X; Cai B; Jin W
Metab Syndr Relat Disord; 2023 Feb; 21(1):48-56. PubMed ID: 36318808
[No Abstract] [Full Text] [Related]
13. The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients - A retrospective register study.
Aro R; Mäkäräinen-Uhlbäck E; Ämmälä N; Rautio T; Ohtonen P; Saarnio J; Meriläinen S
Eur J Surg Oncol; 2020 Sep; 46(9):1656-1662. PubMed ID: 32224072
[TBL] [Abstract][Full Text] [Related]
14. Assessment of muscle mass using chest computed tomography-based quantitative and qualitative measurements in patients with systemic sclerosis: A retrospective study with cross-sectional and longitudinal analyses.
da Rocha DS; Tessari JA; Mainardi NB; Hax V; Gasparin AA; de Oliveira CAV; Garcia TS; Xavier RM; Chakr RMDS
Semin Arthritis Rheum; 2023 Apr; 59():152168. PubMed ID: 36736023
[TBL] [Abstract][Full Text] [Related]
15. Skeletal Muscle Pathological Fat Infiltration (Myosteatosis) Is Associated with Higher Mortality in Patients with Cirrhosis.
Ebadi M; Tsien C; Bhanji RA; Dunichand-Hoedl AR; Rider E; Motamedrad M; Mazurak VC; Baracos V; Montano-Loza AJ
Cells; 2022 Apr; 11(8):. PubMed ID: 35456024
[TBL] [Abstract][Full Text] [Related]
16. Myosteatosis and aortic calcium score on abdominal CT as prognostic markers in non-dialysis chronic kidney disease patients.
Kim A; Lee CM; Kang BK; Kim M; Choi JW
Sci Rep; 2024 Apr; 14(1):7718. PubMed ID: 38565556
[TBL] [Abstract][Full Text] [Related]
17. AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults.
Nachit M; Horsmans Y; Summers RM; Leclercq IA; Pickhardt PJ
Radiology; 2023 Jun; 307(5):e222008. PubMed ID: 37191484
[TBL] [Abstract][Full Text] [Related]
18. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
[TBL] [Abstract][Full Text] [Related]
19. Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt.
Yin L; Chu SL; Lv WF; Zhou CZ; Liu KC; Zhu YJ; Zhang WY; Wang CX; Zhang YH; Lu D; Cheng DL
World J Gastroenterol; 2023 May; 29(18):2875-2887. PubMed ID: 37274064
[TBL] [Abstract][Full Text] [Related]
20. Cancer-Associated Malnutrition and CT-Defined Sarcopenia and Myosteatosis Are Endemic in Overweight and Obese Patients.
Martin L; Gioulbasanis I; Senesse P; Baracos VE
JPEN J Parenter Enteral Nutr; 2020 Feb; 44(2):227-238. PubMed ID: 31012128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
